Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAMIE A TRITT

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1700881760
CMS profile
349834
Location
ATLANTA, GA

General Payments · PY2018–2024

$5,352.73

  • Reported across 122 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$529.87

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $529.87 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
AERIN MEDICAL INC. $260.96 2
GENZYME CORPORATION $138.74 7
OptiNose US, Inc. $63.10 2
GlaxoSmithKline, LLC. $39.39 2
Regeneron Healthcare Solutions, Inc. $27.68 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,250.05 22
PY2019 $426.88 16
PY2020 $324.15 12
PY2021 $843.55 20
PY2022 $507.00 22
PY2023 $471.23 16
PY2024 $529.87 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AERIN MEDICAL INC. $130.48 02/26/2024 Food and Beverage Undisputed 01/23/2026 1144650964 CMS
AERIN MEDICAL INC. $130.48 06/24/2024 Food and Beverage Undisputed 01/23/2026 1144645295 CMS
GENZYME CORPORATION $18.40 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139581108 CMS
GENZYME CORPORATION $7.00 02/14/2024 Food and Beverage Undisputed 01/23/2026 1139581122 CMS
GENZYME CORPORATION $21.88 03/04/2024 Food and Beverage Undisputed 01/23/2026 1139581138 CMS
GENZYME CORPORATION $22.62 05/06/2024 Food and Beverage Undisputed 01/23/2026 1139581154 CMS
GENZYME CORPORATION $29.50 07/08/2024 Food and Beverage Undisputed 01/23/2026 1139581310 CMS
GENZYME CORPORATION $23.04 10/21/2024 Food and Beverage Undisputed 01/23/2026 1139581336 CMS
GENZYME CORPORATION $16.30 12/02/2024 Food and Beverage Undisputed 01/23/2026 1139581370 CMS
GlaxoSmithKline, LLC. $21.98 01/08/2024 Food and Beverage Undisputed 01/23/2026 1116476694 CMS
GlaxoSmithKline, LLC. $17.41 11/04/2024 Food and Beverage Undisputed 01/23/2026 1116452897 CMS
Optinose US, Inc. $36.28 03/13/2024 Food and Beverage Undisputed 01/23/2026 1142173730 CMS
Optinose US, Inc. $26.82 06/17/2024 Food and Beverage Undisputed 01/23/2026 1142173782 CMS
Regeneron Healthcare Solutions, Inc. $27.68 06/11/2024 Food and Beverage Undisputed 01/23/2026 1114224495 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.